Remington 39;s Pharmaceutical Sciences Latest Edition

[Mack Mosely]

RemingtonThe Science and Practice of Pharmacy, Twenty Third Edition, offers a trusted, completely updated source of information for education, training, and development of pharmacists. Published for the first time with Elsevier, this edition includes coverage of biologics and biosimilars as uses of those therapeutics have increased substantially since the previous edition. Also discussed are formulations, drug delivery (including prodrugs, salts, polymorphism. With clear, detailed color illustrations, fundamental information on a range of pharmaceutical science areas, and information on new developments in industry, pharmaceutical industry scientists, especially those involved in drug discovery and development will find this edition of Remington an essential reference. Intellectual property professionals will also find this reference helpful to cite in patents and resulting litigations. Additional graduate and postgraduate students in Pharmacy and Pharmaceutical Sciences will refer to this book in courses dealing with medicinal chemistry and pharmaceutics.

For more than 100 years, Remington has been the definitive reference for all aspects of the science and practice of pharmacy and is used for pharmaceutics, therapeutics, and pharmacy practice courses in primary curricula. Since the first edition was published, pharmacists have used this book as a comprehensive one-stop reference.

Remington: The Science & Practice of Pharmacy is the most widely used textbook and reference work on pharmaceutical sciences in the nation. Publication of the text was begun as Practice of Pharmacy in 1886 by Joseph Price Remington, professor and later dean at the University. Subsequent to his death, the copyright to this text was assigned to the Philadelphia College of Pharmacy (now Saint Joseph's University) by the heirs of Professor Remington.

Remington has provided a comprehensive source of knowledge about the science and practice of pharmacy. The book provides information to help both students and practitioners serve effectively as members of the health professions team. The 22nd edition was published in 2012.

This special bicentennial edition, edited by Professor of Pharmaceutical Sciences Adeboye Adejare Ph.D., celebrates 200 years since the founding of Philadelphia College of Pharmacy in 1821. The founding of the college is regarded as the beginning of pharmacy education and modern pharmacy practice. The text also addresses modern challenges including COVID-19, substance use disorders and medical cannabis.

The 22nd edition of Remington offers a unique array of content in two volumes, covering pharmaceutical science and pharmaceutical practice. Its value is immense for students and practitioners in all areas of the discipline.

Michael M. Crowley, Ph.D. is President of Theridian Technologies, LLC, a boutique Austin, Texas based pharmaceutical consulting group and co-founder of Oticara, Inc., a specialty pharmaceutical company. Theridian provides drug delivery, product development, business development and quality systems / regulatory consulting services to specialty pharma, drug delivery and biotechnology companies. Prior to founding Theridian and Oticara, he served as Vice President, Business Development at PharmaForm. During Dr. Crowley's tenure at PharmaForm he also held the positions of Vice President, Quality Control and Analytical Research and Development and Vice President, Drug Delivery Technology and Manufacturing Services. Dr. Crowley has worked in the field of drug delivery and pharmaceutical research for more than 30 years and has previously been employed in management roles with Monsanto Company, Warner-Jenkinson Company and Mission Pharmacal.

Dr. Crowley received his B.S. degree in Chemistry from the University of Missouri at St. Louis, an M.A. in Organic Chemistry from Washington University and a Ph.D. in Pharmaceutics from The University of Texas at Austin where he studied under Professor James McGinity. His research interests include physical pharmacy and pharmaceutical technology focused on novel drug delivery systems. Dr. Crowley has presented his work in several national and international scientific symposia and conferences. He has authored peer reviewed publications on topics such as hot-melt extrusion, amorphous dispersions, polymer stability, protein binding, analytical characterization of dosage forms, pulmonary drug delivery and the mechanical properties of dosage forms. Dr. Crowley authored a chapter for the 2005 and 2012 editions of Remington: The Science and Practice of Pharmacy. Dr. Crowley is a co-inventor on five patents and several patent applications and has served as a reviewer for several scientific journals.

3a8082e126